These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28236306)

  • 1. p38 mitogen-activated protein kinase regulates mitochondrial function and microvesicle release in riboflavin- and ultraviolet light-treated apheresis platelet concentrates.
    Chen Z; Schubert P; Bakkour S; Culibrk B; Busch MP; Devine DV
    Transfusion; 2017 May; 57(5):1199-1207. PubMed ID: 28236306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment.
    Chen Z; Schubert P; Culibrk B; Devine DV
    Transfusion; 2015 Apr; 55(4):848-57. PubMed ID: 25385501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study.
    Picker SM; Steisel A; Gathof BS
    Transfus Apher Sci; 2009 Apr; 40(2):79-85. PubMed ID: 19233725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Releasates of riboflavin/UV-treated platelets: Microvesicles suppress cytokine-mediated endothelial cell migration/proliferation.
    Schubert P; Culibrk L; Culibrk B; Conway EM; Goodrich RP; Devine DV
    Transfusion; 2021 May; 61(5):1551-1561. PubMed ID: 33629371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered timing of riboflavin and ultraviolet light pathogen inactivation improves platelet in vitro quality.
    Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Yi Q; Thiele T; Greinacher A; Marschner S; Devine DV
    Transfusion; 2017 Aug; 57(8):2026-2034. PubMed ID: 28500654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution.
    Picker SM; Tauszig ME; Gathof BS
    Transfusion; 2012 Mar; 52(3):510-6. PubMed ID: 21981030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction.
    AuBuchon JP; Herschel L; Roger J; Taylor H; Whitley P; Li J; Edrich R; Goodrich RP
    Transfusion; 2005 Aug; 45(8):1335-41. PubMed ID: 16078923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage.
    Schubert P; Culibrk B; Coupland D; Scammell K; Gyongyossy-Issa M; Devine DV
    Transfusion; 2012 Feb; 52(2):397-408. PubMed ID: 21827504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.
    Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Bu D; Bhakta V; Sheffield WP; Goodrich RP; Devine DV
    Transfusion; 2015 Apr; 55(4):815-23. PubMed ID: 25355434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riboflavin and ultraviolet illumination affects selected platelet mRNA transcript amounts differently.
    Klein-Bosgoed C; Schubert P; Devine DV
    Transfusion; 2016 Sep; 56(9):2286-95. PubMed ID: 27443848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution.
    Ignatova AA; Karpova OV; Trakhtman PE; Rumiantsev SA; Panteleev MA
    Vox Sang; 2016 Apr; 110(3):244-52. PubMed ID: 26646605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA multiplex real-time polymerase chain reaction inhibition assay for quality control of pathogen inactivation by ultraviolet C light in platelet concentrates.
    Kim S; Handke W; Gravemann U; Döscher A; Brixner V; Müller TH; Seltsam A
    Transfusion; 2018 Mar; 58(3):758-765. PubMed ID: 29282743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment.
    Schubert P; Coupland D; Culibrk B; Goodrich RP; Devine DV
    Transfusion; 2013 Dec; 53(12):3164-73. PubMed ID: 23521225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates.
    Abonnenc M; Sonego G; Crettaz D; Aliotta A; Prudent M; Tissot JD; Lion N
    Transfusion; 2015 Sep; 55(9):2219-30. PubMed ID: 25873361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling.
    Reid S; Johnson L; Woodland N; Marks DC
    Transfusion; 2012 Oct; 52(10):2094-103. PubMed ID: 22320126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.
    Li J; Lockerbie O; de Korte D; Rice J; McLean R; Goodrich RP
    Transfusion; 2005 Jun; 45(6):920-6. PubMed ID: 15934990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction.
    Picker SM; Oustianskaia L; Schneider V; Gathof BS
    Vox Sang; 2009 Jul; 97(1):26-33. PubMed ID: 19302416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of platelets with riboflavin and ultraviolet light mediates complement activation and suppresses monocyte interleukin-12 production in whole blood.
    Loh YS; Dean MM; Johnson L; Marks DC
    Vox Sang; 2015 Nov; 109(4):327-35. PubMed ID: 25975771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GADD45α is involved in the apoptosis of lymphocytes induced by riboflavin and ultraviolet light.
    Yang P; Wen H; Zhong T; Hu H; Zhu B; Xia K; Xu M; Bian M
    Transfusion; 2017 Mar; 57(3):646-656. PubMed ID: 27905125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.